A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis

Euglycemic diabetic ketoacidosis (DKA), a side effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors, is a triad of high metabolic anion gap acidosis, raised serum and urine ketones, and serum glucose <250 mg/dl. SGLT2 inhibitors cause a carbohydrate deficit by glucosuria, which leads to an...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Khyati, Nair, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611643/
https://www.ncbi.nlm.nih.gov/pubmed/36320965
http://dx.doi.org/10.7759/cureus.29652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611643/
https://www.ncbi.nlm.nih.gov/pubmed/36320965
http://dx.doi.org/10.7759/cureus.29652

Ejemplares similares